TrialBlood2021
Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantation.
Livius Penter et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
30 papers cite it
this papercites it
TrialBlood2021
Livius Penter et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.